Vascular response to paclitaxel-eluting nitinol self-expanding stent in superficial femoral artery lesions: post-implantation angioscopic findings from the SHIMEJI trial (Suppression of vascular wall Healing after IMplantation of drug Eluting peripheral stent in Japanese patients with the Infra inguinal lesion: serial angioscopic observation)
- 12 Downloads
The aim of this study was to elucidate the vascular responses to paclitaxel-eluting stent (Zilver PTX stent) in superficial femoral artery lesion at different elapsed times using angioscopy. Patients who received Zilver PTX stent implantation from five centers were enrolled. We performed angioscopic examinations at 2, 6, and 12 months after implantation and evaluated neointimal coverage (NIC) grade, intra-stent thrombus (IS-Th) grade, and presence of yellow plaque. NIC grade 0 was defined as stent struts exposed; grade 1, struts transparently visible although covered; grade 2, struts embedded in the neointima, but translucent; and grade 3, struts fully embedded and invisible. IS-Th was graded as follows: grade 0 (none), 1 (focal), and 2 (diffusely spread). Angioscopic follow-up evaluation was performed at 2 months (25 patients, 42 lesions), 6 months (18 patients, 23 stents), and 12 months (14 patients, 24 stents) after stent implantation. Dominant NIC grade significantly increased over time; however, 16.3% of the cases had NIC grade 1 or 2 at 12 months. IS-Th grade decreased; however IS-Th and yellow plaque were persistently observed in 62.5% and 83.3% cases, respectively, at 12 months. An ongoing healing response was observed at 12 months after implantation; however, thrombogenic findings were noted. Prolonged dual antiplatelet therapy could potentially enhance the clinical utility of Zilver PTX.
KeywordsZilver PTX Intra-stent thrombus Neointimal coverage Angioscopy Superficial femoral artery Stent thrombosis
There is no financial support with regard to this manuscript.
Compliance with ethical standards
Conflict of interest
Dr. Shinke, Dr. Otake, and Dr. Shite serve as members of the advisory board of Abbott Vascular, Inc. The authors have no conflicts of interest to declare.
A local ethical committee approved this study.
All enrolled study patients provided written informed consent to participate in the study.
- 1.Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB, Machan LS, Snyder SA, O’Leary EE, Ragheb AO, Zeller T (2016) Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the Zilver PTX randomized trial. Circulation 133:1472–483; discussion 83.Google Scholar
- 2.Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB, Zeller T, Roubin GS, Burket MW, Khatib Y, Snyder SA, Ragheb AO, White JK, Machan LS (2011) Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results. Circ Cardiovasc Interv 4:495–504CrossRefGoogle Scholar
- 3.Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB, Snyder SA, O’Leary EE, Tepe G, Scheinert D, Zeller T (2013) Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies. J Am Coll Cardiol 61:2417–2427CrossRefGoogle Scholar
- 11.Montalescot G, Sideris G, Meuleman C, Bal-dit-Sollier C, Lellouche N, Steg PG, Slama M, Milleron O, Collet J, Henry P, Beygui F, Drouet L (2006) A randomized comparison of high clopidogrel loading doses in patients with non-ST-segment elevation acute coronary syndromes: the ALBION (assessment of the best loading dose of clopidogrel to blunt platelet activation, inflammation and ongoing necrosis) trial. J Am Coll Cardiol 48:931–938CrossRefGoogle Scholar
- 12.Nishio R, Shinke T, Otake H, Sawada T, Haraguchi Y, Shinohara M, Toh R, Ishida T, Nakagawa M, Nagoshi R, Kozuki A, Inoue T, Hariki H, Osue T, Taniguchi Y, Iwasaki M, Hiranuma N, Konishi A, Kinutani H, Shite J, Hirata K (2012) Effect of cytochrome P450 2C19 polymorphism on target lesion outcome after drug-eluting stent implantation in Japanese patients receiving clopidogrel. Circ J 76:2348–2355CrossRefGoogle Scholar
- 13.Parodi G, Marcucci R, Valenti R, Gori AM, Migliorini A, Giusti B, Buonamici P, Gensini GF, Abbate R, Antoniucci D (2011) High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI. JAMA 306:1215–1223CrossRefGoogle Scholar
- 19.den Heijer P, Foley DP, Hillege HL, Lablanche JM, van Dijk RB, Franzen D, Morice MC, Serra A, de Scheerder IK, Serruys PW (1994) The 'Ermenonville' classification of observations at coronary angioscopy–evaluation of intra- and inter-observer agreement. European Working Group on Coronary Angioscopy. Eur Heart J 15:815–822CrossRefGoogle Scholar
- 21.Awata M, Nanto S, Uematsu M, Morozumi T, Watanabe T, Onishi T, Iida O, Sera F, Minamiguchi H, Kotani J, Nagata S (2009) Heterogeneous arterial healing in patients following paclitaxel-eluting stent implantation: comparison with sirolimus-eluting stents. JACC Cardiovasc Interv 2:453–458CrossRefGoogle Scholar
- 22.Ueda Y, Matsuo K, Nishimoto Y, Sugihara R, Hirata A, Nemoto T, Okada M, Murakami A, Kashiwase K, Kodama K (2015) In-stent yellow plaque at 1 year after implantation is associated with future event of very late stent failure: the DESNOTE Study (detect the event of very late stent failure from the drug-eluting stent not well covered by neointima determined by angioscopy). JACC Cardiovasc Interv 8:814–821CrossRefGoogle Scholar
- 25.Yokoyama S, Takano M, Yamamoto M, Inami S, Sakai S, Okamatsu K, Okuni S, Seimiya K, Murakami D, Ohba T, Uemura R, Seino Y, Hata N, Mizuno K (2009) Extended follow-up by serial angioscopic observation for bare-metal stents in native coronary arteries: from healing response to atherosclerotic transformation of neointima. Circ Cardiovasc Interv 2:205–212CrossRefGoogle Scholar
- 26.Taniwaki M, Radu MD, Zaugg S, Amabile N, Garcia-Garcia HM, Yamaji K, Jørgensen E, Kelbæk H, Pilgrim T, Caussin C, Zanchin T, Veugeois A, Abildgaard U, Jüni P, Cook S, Koskinas KC, Windecker S, Räber L (2016) Mechanisms of very late drug-eluting stent thrombosis assessed by optical coherence tomography. Circulation 133:650–660CrossRefGoogle Scholar